[1] Wedzicha JE. The heterogeneity of chronic obstructive pulmonary disease. Thorax. 2000;55:631-632.
[2] Regan E, Lynch D, Curran-Everett D, Jeffrey L, Curtis J, Austin J, et al. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9): 1539-49.
[3] Global strategy for the diagnosis, management and prevention of Chronic Obstructive Lung Disease (updated 2018). Global Initiative for Chronic Obstructive Lung Disease(GOLD). 2018. www.goldcopd. Org.Accessed on February 18, 2015.
[4] Chen W, Jian-ying X, Lan Y, Yongjian X, Xiang-yan Zh, Chunxue B, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in china (the china Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391: 1706-1717.
[5] Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370: 765–773.
[6] Le Roux, P. Y.,Siva, S.,Steinfort, D. P, et al.Correlation of 68Ga Ventilation-Perfusion PET/CT with pulmonary function test indices for assessing lung function. Rheumatol Int. 2015;56(11):1718-23.
[7] Van Dijk W, Tan W, Li P, Guo B, Li S, Benedetti A,et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13(1):41-8.
[8] Güder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, et al. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstruction disease in a prospective cohort-study. Respir Res. 2012;13(1):13.
[9] Han M K, Lange P, Anzueto A, Martinez FJ, Jones PW. GOLD COPD categories are not fit for purpose in primary care-author’reply. Lancet Respir Med. 2013;1(1): e17-e18.
[10] Jones PW. Health status and the spiral of decline. COPD. 2009;6(1): 59-63.
[11] Austi A, Hurd S, Jones P, Fabbri LM, Martinez F, Vogelmeier C, et al. FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J. 2013;42(5): 1391.
[12] Global strategy for the diagnosis, management and prevention of Chronic Obstructive Lung Disease (updated 2017). Global Initiative for Chronic Obstructive Lung Disease(GOLD). 2017. www.goldcopd. Org.Accessed on April 05, 2017.
[13] Sun L, Chen Y, Wu R, Lu M, Yao W.Change in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in china. Int J Chron Obtruct Pulmon Dis. 2017;3095-3102.
[14] Carlos C, Ciro CM, Jose M, Mario T. Comparison of 2017 and 2015 Globle Initiative for Obstructive Lung Disease: Impact on Grouping and Outcome. AJRCCM Articles in press. 2017;201707-1363OC.
[15] Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, et al. GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort. Eur Respir. 2017;49:1602518.
[16] Herth FJF, Kirby M, Sieren J, Herth J, Schirm J, Wood S, et al. The Modern Art of Reading Computed Tomography Images of the Lungs: Quantitative CT. Respir. 2018;95 (1): 8-17.
[17] Hackx M, Gyssels E, Severo Garcia T, De Meulder I, Bruyneel M, Van Muylem A, et al.Variability of CT airways measurements in COPD patients between morning and afternoon: comparisons to variability of spirometric measurements. Acad Radiol. 2018; 25(12):1533-1539.
[18] Washko GR1, Criner GJ, Mohsenifar Z, Sciurba FC, Sharafkhaneh A, Make BJ, et al. Computed tomographic-based quantification of emphysema and correlation to pulmonary function and mechanics. COPD. 2008; 5:177-186.
[19] Akira M, Toyokawa K, Inoue Y, Arai T. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. AJR Am J Roentgenol. 2009; 192:267-272.
[20] Matsuoka S, Kurihara Y, Yagihashi K, Nakajima Y. Quantitative assessment of peripheral airway obstruction on paired expiratory/inspiratory thin-section computed tomography in chronic obstructive pulmonary disease with emphysema. J Comput Assist Tomogr. 2007;31:384-389.
[21] Orlandi I, Moroni C, Camiciottoli G, Bartolucci M, Belli G, Villari N,et al. Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease—a comparison of 3 techniques. J Comput Assist Tomogr. 2004; 28:437-442.
[22] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med. 2009;339: 332-336.
[23] Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006;6:6-9.
[24] Crossley D, Renton M, Khan M, Low EV, Turner AM. CT densitometry in emphysema: a systematic review of its clinical utility. Am J Respir Crit Care Med. 2008; 13: 547-563.
[25] Xie X, de Jong PA, Oudkerk M, Wang Y, Ten Hacken NH, Miao J,et al. Morphological measurements in computed tomography correlate with airflow obstruction in chronic obstructive pulmonary disease: Systematic review and meta-analysis. Eur Radiol. 2012;22:2085-2093.
[26] Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, et al.The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One. 2009; 4:e6865.
[27] Dransfield MT, Washko GR, Foreman MG, Estepar RSJ, Reilly J, Bailey WC. Gender differences in the severity of CT emphysema in COPD. Chest. 2007; 132:464–470.
[28] Zhang Y, Tu YH, Fei GH. The COPD assessment test correlates well with the computed tomography measurements in COPD patients in China. Int J Chron Obstruct Pulmon Dis. 2015;10:507-14.
[29] Leader JK, Zheng B, Sciurba FC. The relation of airway size to lung function. Proc SPIE Med Imaging. 2008; 6916:691623.
[30] Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, et al .Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008; 186:157–165.
[31] Park YS, Seo JB, Kim N, Chae EJ, Oh YM, Lee SD, et al.Texture-based quantification of pulmonary emphysema on high-resolution computed tomography: Comparison with density-based quantification and correlation with pulmonary function test. Invest Radiol. 2008; 43:395–402.
[32] Pauls S, Gulkin D, Feuerlein S, Muche R, Krüger S, Schmidt SA, et al.Assessment of COPD severity by computed tomography: correlation with lung functionaltesting. Clin Imaging. 2010;34:172–178.
[33] Washko GR1, Dransfield MT, Estépar RS, Diaz A, Matsuoka S, Yamashiro T, et al. Airway wall attenuation: a biomarker of airway disease in subjects with COPD. J Appl Physiol. 2009; 107:185–191.
[34] Yamashiro T, Matsuoka S, Bartholmai BJ, San José Estépar R, Ross JC, Diaz A, et al. Collapsibility of lung volume by paired inspiratory and expiratory CT scans. Correlations with lung function and mean lung density. Acad Radiol. 2010;17:489–495.
[35] Zhang J, Yu TL, Wu Q, Ye N, Cao Y, Zhou N.Quantitative MSCT study of lung attenuation in patients with chronic obstructive pulmonary disease. Chin J Med Imaging Technol. 2008;24:1611–1614 .
[36] Yamashiro T, Matsuoka S, Estépar RS, Dransfield MT, Diaz A, Reilly JJ, et al. Quantitative assessment of bronchial wall attenuation with thin-section CT: an indicator of airflow limitation in chronic obstructive pulmonary disease. Am J Roentgenol. 2010; 195:363–369.
[37] Hesselbacher SE, Ross R, Schabath MB, Smith EO, Perusich S, Barrow N, et al. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health. 2011;8:1324–1340.
[38] Ohno Y, Koyama H, Yoshikawa T, Matsumoto K, Aoyama N, Onishi Y, et al. Comparison of capability of dynamic O2-enhanced MRI and quantitative thinsection MDCT to assess COPD in smokers. Eur J Radiol. 2011;81(5):1068-75.
[39] Iwasawa T, Takahashi H, Ogura T, Asakura A, Gotoh T, Shibata H, et al. Influence of the distribution of emphysema on diaphragmatic motion in patients with chronic obstructive pulmonary disease. Jpn J Radiol. 2011;29:256-64.
[40] Jin LF, Miao JT, Li ZY, Xie XQ, Dai XM. Study of voxel index from multislice CT in evaluating chronic obstructive pulmonary disease air-trapping. Chin J Med Imaging Technol. 207;23:1033-1036.
[41] Capaldi DP, Zha N, Guo F, Pike D, McCormack DG, Kirby M, et al.(2016) Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps. Radiology. 2016;279:597-608.
[42] Gawlitza J, Haubenreisser H, Henzler T, Akin I, Schönberg S, Borggrefe M,et al. Finding the right spot: Where to measure airway parameters in patients with COPD. Eur J Radiol. 2018;104:87-93.
[43] Nishio, M. Nakane, K. Tanaka, Y. Validation of the homology method for emphysema quantification: Preliminary study. Int J Chron Obstruct Pulmon Dis. 2016; 11:2125–2137.
[44] Hoshino, M.Ohtawa, J. Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients. Respirology. 2014; 19(3):403-10.
[45] Ju J, Li R, Gu S, Leader JK, Wang X, Chen Y, et al. Impact of emphysema heterogeneity on pulmonary function. PLoS One. 2014;9(11):e113320.
[46] Saruya S, Matsuoka S, Yamashiro T, Matsushita S, Fujikawa A, Yagihashi K. et al. Quantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans. Clin Physiol Funct Imaging. 2016; 36(3):211-7.
[47] Kim, S. S. Seo, J. B. Lee, H. Y. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images-comparison with quantitative CT and pulmonary function test in the COPD Gene study. Radiology. 2013; 266:626-35.
[48] Kim EY, Seo JB, Lee HJ, Kim N, Lee E, Lee SM, et al. Detailed analysis of the density change on chest CT of COPD using non-rigid registration of inspiration /expiration CT scans. Eur Radiol. 2015; 25(2):541-9.
[49] Kundu S, Gu S, Leader JK, Tedrow JR, Sciurba FC, Gur D, et al. Assessment of lung volume collapsibility in chronic obstructive lung disease patients using CT. Eur Radiol. 2013; 23(6):1564-72.
[50] Kurashima K, Hoshi T, Takaku Y, Kanauchi T, Nakamoto K, Ueda M, et al.Changes in the airway lumen and surrounding parenchyma in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:523-32.
[51] Lee SM, Seo JB, Lee SM, Kim N, Oh SY, Oh YM. Optimal threshold of subtraction method for quantification of air-trapping on coregistered CT in COPD patients. Eur Radiol. 2016; 26(7):2184-92.
[52] Haraguchi M, Nakamura H, Sasaki M, Miyazaki M, Chubachi S, Takahashi S, et al. Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients. BMC Res Notes. 2016; 4;9:7.
[53] Occhipinti M, Paoletti M, Bigazzi F, Camiciottoli G, Inchingolo R, Larici AR, et al. Emphysematous and Non emphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. Radiology. 2018; 287(2):683-692.
[54] Oh SY, Lee M, Seo JB, Kim N, Lee SM, Lee JS,et al.Size variation and collapse of emphysema holes at inspiration and expiration CT scan: evaluation with modified length scale method and image co-registration. Int J Chron Obstruct Pulmon Dis. 2017;13 (12):2043-2057.
[55] Ohno Y, Onishi Y, Takenaka D, Matsumoto S, Nishimura Y, Sugimura K,et al. Comparison of capability of dynamic O(2)-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers. Eur J Radiol. 2012;81(5):1068-75.
[56] Karayama M, Inui N, Mori K, Kono M, Hozumi H, Suzuki Y,et al. Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD. Sci Rep. 2017; 8(7):41709.
[57] Sasaki T1, Takahashi K, Takada N, Ohsaki Y. Ratios of peripheral-to-central airway lumen area and percentage wall area as predictors of severity of chronic obstructive pulmonary disease. AJR Am J Roentgenol. 2014; 203:78-84.
[58] Šileikienė V, Urbonas M, Matačiūnas M, Norkūnienė J. Relationships between pulmonary function test parameters and quantitative computed tomography measurements of emphysema in subjects with chronic obstructive pulmonary disease. Acta Med Litu. 2017; 24(4):209-218.
[59] Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N, Salome CM, et al. The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest. 2012;142(2):312-319.
[60] Wang G, Wang L, Ma Z, Zhang C, Deng K. Quantitative emphysema assessment of pulmonary function impairment by computed tomography in chronic obstructive pulmonary disease. J Comput Assist Tomogr. 2015; 39(2):171-5.
[61] Yahaba M, Kawata N, Iesato K, Matsuura Y, Sugiura T, Kasai H, et al. The effects of emphysema on airway disease: correlations between multi-detector CT and pulmonary function tests in smokers. Eur J Radiol. 2014;83(6):1022-1028.
[62] Hasegawa M, Nasuhara Y, Onodera Y, Makita H, Nagai K, Fuke S, ,et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;15;173(12):1309-15.
[63] Camiciottoli G, Bartolucci M, Maluccio NM, Moroni C, Mascalchi M, Giuntini C, et al. Spirometrically gated high-resolution CT findings in COPD—lung attenuation vs lung function and dyspnea severity. Chest. 2006; 129(3):558-64.
[64] O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Broberg P, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax. 2004;59(10):837-42.
[65] Zaporozhan J, Ley S, Eberhardt R, Weinheimer O, Iliyushenko S, Herth F,et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest. 2005; 128(5):3212-20.
[66] Washko GR, Diaz AA, Kim V, Barr RG, Dransfield MT, Schroeder J,et al. Computed tomographic measures of airway morphology in smokers and never-smoking normals. J Appl Physiol. 2014;15;116(6):668-73.
[67] Kim, V. Davey, A. Comellas, A. P. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPD Gene study. Respir Res. 2014;15:52.
[68] Falaschi F, Miniati M, Battolla L, Filippi E, Sostman HD, Laiolo E,et al. Quantification of pulmonary emphysema with computerized tomography. Comparison with various methods. Radiol Med.1995; 90(1-2):16-23.
[69] Iwasawa T, Takahashi H, Ogura T, Asakura A, Gotoh T, Kagei S,et al.Correlation of lung parenchymal MR signal intensity with pulmonary function tests and quantitative computed tomography (CT) evaluation: a pilot study. J Magn Reson Imaging.2007;26(6):1530-6.
[70] Deveci F, Murat A, Turgut T, Altuntas E, Muz MH. Airway wall thickness in patients with COPD and healthy current smokers and healthy non-smokers: assessment with high resolution computed tomographic scanning. Respiration.2004;71(6):602-10.